News | December 30, 2013

RaySearch, TomoTherapy Cancel License Agreement

December 30, 2013 — RaySearch Laboratories and TomoTherapy Inc. (now Accuray) entered a software licensing and development agreement in 2007, under which RaySearch developed a product named SharePlan. TomoTherapy launched Shareplan in 2009.
SharePlan is a treatment planning solution that enables transfer of treatment plans between TomoTherapy systems and conventional linear accelerators. The product uses algorithms to automatically generate a selection of deliverable intensity-modulated radiation therapy (IMRT) plans based on an existing TomoTherapy treatment plan. This time-saving concept is a tool for optimizing patient benefit and throughput at clinics that have a mixed environment with both TomoTherapy systems and conventional linear accelerators.
Now RaySearch and Accuray have agreed to cancel the agreement and end the partnership. SharePlan functionality will continue to be available for new and existing customers as an integrated module in RaySearch’s RayStation treatment planning system that is sold and marketed by RaySearch. Existing SharePlan customers will be offered a free upgrade to RayStation.
“Since the original agreement was signed, a lot has changed for both companies, so this solution makes good sense for both parties,” said Johan Löf, CEO, RaySearch. “RayStation was not available four years ago, so back then a stand-alone application was the best solution. Now however, we can offer the same functionality in RayStation, which is evolving very rapidly and also gives the TomoTherapy System users the option to select other features and advanced treatment planning tools. This is attractive for the customers and Accuray alike, as it expands the product offering for these customers.”

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Overlay Init